Infusion therapy

ICU Medical, Inc. Announces Time of First Quarter 2020 Earnings Conference Call

Retrieved on: 
Monday, April 20, 2020
ICU Medical, Infusion therapy, NASDAQ, Economy of the United States, Companies, Financial markets

SAN CLEMENTE, Calif., April 20, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2020 earnings release and conference call.

Key Points: 
  • SAN CLEMENTE, Calif., April 20, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced the time of its first quarter 2020 earnings release and conference call.
  • The Company will release its first quarter 2020 results on Thursday, May 7th, 2020 at approximately 4:00 p.m.
  • ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m.
  • ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications.

Option Care Health Collaborating with Leading Health Systems to Accelerate Patient Discharges During the COVID-19 Pandemic

Retrieved on: 
Tuesday, April 14, 2020
Infusion therapy, Hospital, Draft:Primary Care Occupational Therapy Annotated Bibliography

Option Care Health provides essential infusion services that enable patients to transition home from the hospital sooner, freeing up beds for critically ill COVID-19 patients.

Key Points: 
  • Option Care Health provides essential infusion services that enable patients to transition home from the hospital sooner, freeing up beds for critically ill COVID-19 patients.
  • Serving patients in all 50 states, Option Care Health is easing the burden on strained health systems in critical markets.
  • Staff members can call an Option Care Health COVID-19 hotline 24/7 to address questions regarding their health or a patients health.
  • The Option Care Health clinical team elevates the infusion therapy experience through customized care plans specific to every patient.

B. Braun Receives FDA Emergency Use Authorization for Use of Infusion Pumps with Nebulizers to Treat COVID-19 Patients

Retrieved on: 
Monday, April 13, 2020
Health, Medicine, Dosage forms, Respiratory therapy, Intensive care medicine, Infusion pump, Nebulizer, B. Braun Melsungen, Respiratory distress syndrome, Infusion therapy, Acute respiratory distress syndrome

Studies have shown that using infusion pumps with nebulizers can help provide steady, controlled delivery of nebulized medication to patients with acute respiratory distress syndrome (ARDS).

Key Points: 
  • Studies have shown that using infusion pumps with nebulizers can help provide steady, controlled delivery of nebulized medication to patients with acute respiratory distress syndrome (ARDS).
  • The EUA also authorizes ground medical transport use of the Infusomat Space Volumetric Infusion Pump System.
  • B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry.
  • B. Braun Medical is headquartered in Bethlehem, PA and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculapand CAPS.

Outlook into the Global Home Infusion Therapy Market to 2027 - Increasing Geriatric Population Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, March 16, 2020
Managed care, Health, Medical devices, Health sciences, Health, Articles, Infusion therapy, Therapy

The global home infusion therapy market size is expected to reach USD 41.6 billion by 2027, according to this report registering a CAGR of 7.3% over the forecast period.

Key Points: 
  • The global home infusion therapy market size is expected to reach USD 41.6 billion by 2027, according to this report registering a CAGR of 7.3% over the forecast period.
  • Increasing incidences of hospital-acquired infections are some of the major factors contributing to the market growth.
  • Home infusion therapy is considered an alternative to an extended stay in hospitals or nursing homes for patients suffering from chronic diseases.
  • Several government and non-government programs are carried out in order to spread awareness among people regarding home infusion therapy.

ICU Medical, Inc. to Present at the Raymond James 41st Annual Institutional Investors Conference

Retrieved on: 
Friday, February 28, 2020
ICU Medical, Infusion therapy, Intensive care medicine

SAN CLEMENTE, Calif., Feb. 28, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond James 41st Annual Institutional Investors Conference, held on March 1-4, 2020 in Orlando, FL.

Key Points: 
  • SAN CLEMENTE, Calif., Feb. 28, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the Raymond James 41st Annual Institutional Investors Conference, held on March 1-4, 2020 in Orlando, FL.
  • ICU Medicals presentation will be on Monday, March 2, 2020 at 3:25 PM Eastern Time.
  • The presentation will be webcast live and can be accessed by going to the Companys website at http://www.icumed.com , clicking on the Investors tab and clicking on the Event Calendar tab.
  • ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy, and critical care applications.

Home Infusion Therapy Market to Cross $41 Billion by 2027 - Key Players are B. Braun Melsungen, Baxter, Caesarea Medical Electronics, CareFusion Corp, and Fresenius Kabi, Amongst Others

Retrieved on: 
Wednesday, February 26, 2020
Health sciences, Health, Articles, Infusion therapy, Therapy

The global home infusion therapy market size is expected to reach USD 41.6 billion by 2027, registering a CAGR of 7.3% over the forecast period.

Key Points: 
  • The global home infusion therapy market size is expected to reach USD 41.6 billion by 2027, registering a CAGR of 7.3% over the forecast period.
  • Home infusion therapy is considered an alternative to an extended stay in hospitals or nursing homes for patients suffering from chronic diseases.
  • Several government and non-government programs are carried out in order to spread awareness among people regarding home infusion therapy.
  • Technological developments in home infusion therapy devices are also anticipated to make therapy more convenient and user-friendly for patients.

Enclara Pharmacia Appoints Scott Quilty as Chief Commercial Officer

Retrieved on: 
Wednesday, February 26, 2020
Managed care, Pharmaceutical, Health, Health, Articles, Medicinal chemistry, Pharmacy, Quilty, Pharmacia, Infusion therapy, Hospice

Enclara Pharmacia , the market leader in comprehensive pharmacy management services to the hospice industry, announces the appointment of Scott Quilty as Chief Commercial Officer to drive Enclaras strategic direction around business development, client services and marketing.

Key Points: 
  • Enclara Pharmacia , the market leader in comprehensive pharmacy management services to the hospice industry, announces the appointment of Scott Quilty as Chief Commercial Officer to drive Enclaras strategic direction around business development, client services and marketing.
  • View the full release here: https://www.businesswire.com/news/home/20200226005125/en/
    Im excited to welcome a leader of Scotts caliber to our great team, says Andy Horowitz, CEO of Enclara.
  • Scott has proven experience leading high performing organizations and achieving ambitious growth targets through cross-functional collaboration, innovation and organizational development.
  • Quilty joins Enclara after over two decades with B. Braun Medical Inc., a leader in infusion therapy and pain management.

Eitan Group Appoints Igal Shany as CEO of Eitan Group's Q Core Medical Ltd., and Eitan Group President

Retrieved on: 
Tuesday, February 18, 2020
Eitan, Igal, Infusion therapy

NETANYA, Israel, Feb. 18, 2020 /PRNewswire/ -- Eitan Group , a global leader in advanced infusion therapy solutions across the care continuum, announced the appointment of Igal Shany as the CEO of Q Core Medical Ltd. and President of Eitan Group.

Key Points: 
  • NETANYA, Israel, Feb. 18, 2020 /PRNewswire/ -- Eitan Group , a global leader in advanced infusion therapy solutions across the care continuum, announced the appointment of Igal Shany as the CEO of Q Core Medical Ltd. and President of Eitan Group.
  • It was at Saifun, where he served as CFO, that he first collaborated with Eitan Group Founder Dr. Boaz Eitan.
  • As new CEO of Q Core Medical and President of Eitan Group, Igal will be responsible for driving further expansion of the company across the care continuum with its full suite of innovative infusion products.
  • "We're excited that Igal will be expanding his role with Eitan Group," said Boaz Eitan, Chairman of the Board for Eitan Group.

ICU Medical, Inc. Announces Time of Fourth Quarter and Fiscal Year 2019 Earnings Conference Call

Retrieved on: 
Thursday, February 6, 2020
ICU Medical, Infusion therapy, NASDAQ, Economy of the United States, Companies, Financial markets

The Company will release its fourth quarter and fiscal year 2019 results on Thursday, February 27th, 2020 at approximately 4:00 p.m.

Key Points: 
  • The Company will release its fourth quarter and fiscal year 2019 results on Thursday, February 27th, 2020 at approximately 4:00 p.m.
  • ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m.
  • ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications.
  • More information about ICU Medical, Inc. can be found at www.icumed.com .

ICU Medical, Inc. to Present at the J.P. Morgan 38th Annual Healthcare Conference

Retrieved on: 
Tuesday, January 7, 2020
ICU Medical, Infusion therapy, Intensive care medicine

SAN CLEMENTE, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P. Morgan 38th Annual Healthcare Conference, held on January 13-16, 2020 in San Francisco, CA.

Key Points: 
  • SAN CLEMENTE, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, today announced that Company management will present at the J.P. Morgan 38th Annual Healthcare Conference, held on January 13-16, 2020 in San Francisco, CA.
  • ICU Medicals presentation will be on Wednesday, January 15, 2020 at 2:30 p.m. PST (5:30 p.m. EST).
  • ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medical products used in infusion therapy, and critical care applications.
  • More information about ICU Medical, Inc. can be found at www.icumed.com .